Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
$208M |
| 2 |
Norfolk Southern
NSC
|
$145M |
| 3 |
Insmed
INSM
|
$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$136M |
| 5 |
Soleno Therapeutics
SLNO
|
$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$355M |
| 2 |
Royalty Pharma
RPRX
|
$334M |
| 3 |
McDonald's
MCD
|
$198M |
| 4 |
Union Pacific
UNP
|
$188M |
| 5 |
HES
Hess
HES
|
$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Alaska Air
ALK
$7.28B
| – | – |
-943,064
| Closed | -$61.1M |
|
877
Ares Management
ARES
$38.9B
| – | – |
-232,000
| Closed | -$41.1M |
|
878
Arcutis Biotherapeutics
ARQT
$2.06B
| – | – |
-100,000
| Closed | -$1.39M |
|
879
Algoma Steel
ASTL
$538M
| – | – |
-500,000
| Closed | -$4.89M |
|
880
Avient
AVNT
$3.45B
| – | – |
-85,000
| Closed | -$3.47M |
|
881
BILL Holdings
BILL
$5.24B
| – | – |
-7,013
| Closed | -$594K |
|
882
Birkenstock
BIRK
$9.23B
| – | – |
-175,000
| Closed | -$9.92M |
|
883
Brown & Brown
BRO
$31.3B
| – | – |
-101,800
| Closed | -$10.4M |
|
884
Brixmor Property Group
BRX
$8.63B
| – | – |
-450,000
| Closed | -$12.5M |
|
885
Braze
BRZE
$3.5B
| – | – |
-10,000
| Closed | -$419K |
|
886
Bentley Systems
BSY
$16.3B
| – | – |
-15,000
| Closed | -$701K |
|
887
Carrier Global
CARR
$55.8B
| – | – |
-285,598
| Closed | -$19.5M |
|
888
Cameco
CCJ
$33B
| – | – |
-50,000
| Closed | -$2.57M |
|
889
Crown Holdings
CCK
$11B
| – | – |
-361,411
| Closed | -$29.9M |
|
890
Celanese
CE
$5.34B
| – | – |
-142,100
| Closed | -$9.83M |
|
891
Carlyle Group
CG
$23.1B
| – | – |
-89,600
| Closed | -$4.52M |
|
892
Cullinan Oncology
CGEM
$413M
| – | – |
-1,030,438
| Closed | -$12.6M |
|
893
CG Oncology
CGON
$2.52B
| – | – |
-200,000
| Closed | -$5.74M |
|
894
Clean Energy Fuels
CLNE
$546M
| – | – |
-300,000
| Closed | -$753K |
|
895
CMS Energy
CMS
$21.4B
| – | – |
-279,161
| Closed | -$18.6M |
|
896
Capital One
COF
$142B
| – | – |
-78,522
| Closed | -$14M |
|
897
Cogent Biosciences
COGT
$1.82B
| – | – |
-4,300,000
| Closed | -$33.5M |
|
898
Corbus Pharmaceuticals
CRBP
$121M
| – | – |
-528,937
| Closed | -$6.24M |
|
899
Crinetics Pharmaceuticals
CRNX
$3.35B
| – | – |
-65,000
| Closed | -$3.32M |
|
900
EastGroup Properties
EGP
$8.97B
| – | – |
-18,771
| Closed | -$3.01M |
|